|
Pastor Quirante FA, Pastor-Pérez FJ, Manzano-Fernández S, Rivas NL, Pérez PP, Hernández JP, Gimeno-Blanes JR. Unexpected autopsy findings after sudden cardiac death: cardiovascular myxoedema and endocardial fibroelastosis. Int J Cardiol. 2015 Mar 1;182:281-3. doi: 10.1016/j.ijcard.2014.12.156. PubMed PMID: 25585372.
AÑO: 2015; IF: 4.638
|
25585372
|
Lopez-Ayala JM, Gimeno JR. Author's reply: To PMID 24938629. Europace. 2015 Feb;17(2):334-7. doi: 10.1093/europace/euu285. PubMed PMID: 25395157.
AÑO: 2015; IF: 4.021
|
|
Guttmann OP, Pavlou M, O'Mahony C, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, Garcia-Pavia P, McKenna WJ, Omar RZ, Elliott PM; Hypertrophic Cardiomyopathy Outcomes Investigators.. Prediction of thrombo-embolic risk in patients with hypertrophic cardiomyopathy (HCM Risk-CVA). Eur J Heart Fail. 2015 Aug;17(8):837-45. doi: 10.1002/ejhf.316. PubMed PMID: 26183688; PubMed Central PMCID: PMC4737264.
AÑO: 2015; IF: 5.135
|
|
SEC Working Group for the 2014 ESC Guidelines on Diagnosis and Management of Hypertrophic Cardiomyopathy.; Expert Reviewers for the ESC 2014 Guidelines on the Diagnosis and Management of Hypertrophic Cardiomyopathy.; SEC Clinical Practice Guidelines Committee.. Comments on the 2014 ESC Guidelines on the diagnosis and management of hypertrophic cardiomyopathy. A critical view from the perspective of Spanish cardiology. Rev Esp Cardiol (Engl Ed). 2015 Jan;68(1):4-9. doi: 10.1016/j.rec.2014.10.011. PubMed PMID: 25553935.
AÑO: 2015; IF: 4.596
|
|
López-Ayala JM, Gómez-Milanés I, Sánchez Muñoz JJ, Ruiz-Espejo F, Ortíz M, González-Carrillo J, López-Cuenca D, Oliva-Sandoval MJ, Monserrat L, Valdés M, Gimeno JR. Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. Europace. 2014 Dec;16(12):1838-46. doi: 10.1093/europace/euu128. PubMed PMID: 24938629.
AÑO: 2014; IF: 3.67
|